Neuberger Berman Group LLC - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,304,792
+14.5%
241,846
+32.1%
0.00%0.0%
Q1 2023$2,013,165
-18.2%
183,015
+10.0%
0.00%0.0%
Q4 2022$2,462,395
-2.4%
166,378
+26.1%
0.00%
-33.3%
Q3 2022$2,522,000
-13.4%
131,979
-3.5%
0.00%0.0%
Q2 2022$2,913,000
+17.0%
136,724
+5.8%
0.00%
+50.0%
Q1 2022$2,490,000
-1.7%
129,276
+5.9%
0.00%0.0%
Q4 2021$2,532,000
-13.2%
122,097
+0.0%
0.00%
-33.3%
Q3 2021$2,916,000
-11.7%
122,087
+0.7%
0.00%0.0%
Q2 2021$3,304,000
-4.6%
121,216
+1.3%
0.00%0.0%
Q1 2021$3,462,000119,6700.00%
Other shareholders

There were no reported owners of ARCUTIS BIOTHERAPEUTICS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders